Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders: A Mood Resilience Trial.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2014
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Depression; Mental disorders; Mood disorders; Traumatic stress disorders
- Focus Therapeutic Use
- 08 Mar 2011 Planned end date changed from 1 Apr 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.
- 08 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Nov 2010 Actual initiation date (Nov 2010) added as reported by ClinicalTrials.gov.